Document is current
Any future updates will be listed below
-
Authors
Blessing, Charlotte http://orcid.org/0000-0002-5786-661X
Apelt, Katja
van den Heuvel, Diana
Gonzalez-Leal, Claudia
Rother, Magdalena B.
van der Woude, Melanie
González-Prieto, Román http://orcid.org/0000-0001-8997-2321
Yifrach, Adi
Parnas, Avital
Shah, Rashmi G.
Kuo, Tia Tyrsett http://orcid.org/0000-0002-3532-2718
Boer, Daphne E. C.
Cai, Jin
Kragten, Angela
Kim, Hyun-Suk
Schärer, Orlando D.
Vertegaal, Alfred C. O.
Shah, Girish M. http://orcid.org/0000-0002-9291-1164
Adar, Sheera
Lans, Hannes http://orcid.org/0000-0003-4417-5358
van Attikum, Haico
Ladurner, Andreas G. http://orcid.org/0000-0003-3835-232X
Luijsterburg, Martijn S. http://orcid.org/0000-0001-5796-6541
-
Funding
Funding for this research was provided by:
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (ALW.016.161.320)
- License Information
-
More Information
Article History
Received: 23 April 2021
Accepted: 29 June 2022
First Online: 13 August 2022
Competing interests
: A.G.L. is a founder, shareholder, and managing director of Eisbach Bio, a biotech developing small molecule therapeutics. The remaining authors declare no competing interests.
